In Person

Life Science Washington Venture Investment Partnering Forum with Bristol-Myers Squibb

March 1 – 2, 2018
Event details
March 1 – 2, 2018
6:00 pm
Seattle, WA

Event summary

Cooley is pleased to sponsor the Venture Investment Partnering Forum with Bristol-Myers Squibb. Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Executives from Bristol-Myers Squibb will be in Seattle March 1 – 2 for a plenary and networking reception and 1:1 meetings with local companies, entrepreneurs and research groups. There are no fees for either of these events. Companies and groups chosen for 1:1 meetings must be Life Science Washington members.

To apply for a 1:1 meeting please complete an application by February 9. For more information, please email Amanda Richardson.

Locations
March 1 – Life Science Washington
March 2 – Cooley's Seattle office

Additional event details

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.